Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05105308 · ClinicalTrials.gov registry record · NA

Chompions! A Treatment Study for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)

A NA study of ARFID and Picky Eating, sponsored by Duke University.

Completed
Registry status
NA
Development phase
203
Enrollment target
1
Study location

NCT05105308 is a NA study of ARFID and Picky Eating that has completed, run by Duke University. The registered enrollment target is 203 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05105308, a NA study of ARFID and Picky Eating, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
203 participants
Enrollment target
1
Study location

Study Summary

Avoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID often begins in early childhood so it is important to treat children in early in life as possible to prevent any negative consequences of poor nutrition. There are currently no treatments for young children with ARFID. The investigators have developed two different study programs and the purpose of this study is to test them out and see if they help children with ARFID and to learn more about how these study programs work.

Interventions

  • BEHAVIORAL Family Assisted Diet (FAD)
  • BEHAVIORAL Feeling and Body Investigator_ARFID Division (FBI-ARFID)

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2022-02-10
Est. Completion 2025-09-29
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05105308

The ClinicalTrials.gov registry entry for NCT05105308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with ARFID appearing as the primary indexed condition, and to 2 interventions - of which Family Assisted Diet (FAD) is the first listed.

NCT05105308 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05105308 about?

NCT05105308 is a clinical study titled "Chompions! A Treatment Study for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)". Avoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID often begins in early ...

What is the current status of trial NCT05105308?

This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2022-02-10. Estimated completion is 2025-09-29.

What conditions does trial NCT05105308 study?

This clinical trial studies the following conditions: ARFID, Picky Eating, Eating Disorders in Children.

What interventions are being tested in trial NCT05105308?

The interventions under investigation include: Family Assisted Diet (FAD) (BEHAVIORAL), Feeling and Body Investigator_ARFID Division (FBI-ARFID) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05105308?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05105308 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ARFID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.